125 related articles for article (PubMed ID: 2615357)
1. Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist.
Snyder BW; Winneker RC; Batzold FH
J Steroid Biochem; 1989 Dec; 33(6):1127-32. PubMed ID: 2615357
[TBL] [Abstract][Full Text] [Related]
2. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
Juniewicz PE; McCarthy M; Lemp BM; Barbolt TA; Shaw C; Hollenbaugh DM; Winneker RC; Reel JR; Batzold FH
Endocrinology; 1990 May; 126(5):2625-34. PubMed ID: 1691701
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mechanism of action of Win 49596: a steroidal androgen receptor antagonist.
Winneker RC; Wagner MM; Batzold FH
J Steroid Biochem; 1989 Dec; 33(6):1133-8. PubMed ID: 2615358
[TBL] [Abstract][Full Text] [Related]
4. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
Furr BJ; Tucker H
Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
[TBL] [Abstract][Full Text] [Related]
5. Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Juniewicz PE; Barbolt TA; Egy MA; Frenette G; Dube JY; Tremblay RR
Prostate; 1990; 17(2):101-11. PubMed ID: 2169047
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.
Juniewicz PE; Fetrow N; Marinelli J; Wolf M; Young E; Lamb J; Isaacs JT
Prostate; 1991; 18(2):105-15. PubMed ID: 2006117
[TBL] [Abstract][Full Text] [Related]
7. Comparison of anti-androgenic activity of flutamide, vinclozolin, procymidone, linuron, and p, p'-DDE in rodent 10-day Hershberger assay.
Kang IH; Kim HS; Shin JH; Kim TS; Moon HJ; Kim IY; Choi KS; Kil KS; Park YI; Dong MS; Han SY
Toxicology; 2004 Jul; 199(2-3):145-59. PubMed ID: 15147789
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological profile of RU 58642, a potent systemic antiandrogen for the treatment of androgen-dependent disorders.
Battmann T; Branche C; Bouchoux F; Cerede E; Philibert D; Goubet F; Teutsch G; Gaillard-Kelly M
J Steroid Biochem Mol Biol; 1998 Jan; 64(1-2):103-11. PubMed ID: 9569015
[TBL] [Abstract][Full Text] [Related]
9. ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen.
Furr BJ; Valcaccia B; Curry B; Woodburn JR; Chesterson G; Tucker H
J Endocrinol; 1987 Jun; 113(3):R7-9. PubMed ID: 3625091
[TBL] [Abstract][Full Text] [Related]
10. No androgenic/anti-androgenic effects of bisphenol-A in Hershberger assay using immature castrated rats.
Kim HS; Han SY; Kim TS; Kwack SJ; Lee RD; Kim IY; Seok JH; Lee BM; Yoo SD; Park KL
Toxicol Lett; 2002 Sep; 135(1-2):111-23. PubMed ID: 12243870
[TBL] [Abstract][Full Text] [Related]
11. Effect of the steroidal androgen receptor antagonist Win 49,596 on steroid-induced benign prostatic hyperplasia in the castrate beagle dog.
Juniewicz PE; Lemp BM; Barbolt TA; LaBrie TK; McCarthy M; Reel JR; Batzold FH
Prostate; 1990; 16(1):1-14. PubMed ID: 1689481
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
13. Antiandrogenic steroidal sulfonylpyrazoles.
Christiansen RG; Bell MR; D'Ambra TE; Mallamo JP; Herrmann JL; Ackerman JH; Opalka CJ; Kullnig RK; Winneker RC; Snyder BW
J Med Chem; 1990 Aug; 33(8):2094-100. PubMed ID: 2374140
[TBL] [Abstract][Full Text] [Related]
14. Bioassay of steroid hormone agonist and antagonist activities of anti-androgens on mammary gland, seminal vesicles and spleen of male mice.
Skarda J
J Vet Med A Physiol Pathol Clin Med; 2003 May; 50(4):204-12. PubMed ID: 12948158
[TBL] [Abstract][Full Text] [Related]
15. Effect of the antiandrogen, WIN 49,596, on the descent of the testis in the male rat.
Bluestein D; Lemmi CA; Miller L; Geesaman B; Rajfer J
J Urol; 1991 May; 145(5):1103-5. PubMed ID: 2016802
[TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of a 5-day Hershberger assay utilizing mature male rats and a pubertal male assay for detection of flutamide's antiandrogenic activity.
Yamada T; Kunimatsu T; Sako H; Yabushita S; Sukata T; Okuno Y; Matsuo M
Toxicol Sci; 2000 Feb; 53(2):289-96. PubMed ID: 10696777
[TBL] [Abstract][Full Text] [Related]
17. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of flutamide action on prostatic and testicular functions in the rat.
Marchetti B; Labrie F
J Steroid Biochem; 1988 Jun; 29(6):691-8. PubMed ID: 2838689
[TBL] [Abstract][Full Text] [Related]
19. Antiandrogenic activity and endocrinological profile of a novel antiandrogen, TZP-4238, in the rat.
Mieda M; Ohta Y; Saito T; Takahashi H; Shimazawa E; Miyasaka K
Endocr J; 1994 Aug; 41(4):445-52. PubMed ID: 8528361
[TBL] [Abstract][Full Text] [Related]
20. Castration levels of plasma testosterone have potent stimulatory effects on androgen-sensitive parameters in the rat prostate.
Marchetti B; Poulin R; Plante M; Labrie F
J Steroid Biochem; 1988 Oct; 31(4A):411-9. PubMed ID: 2845194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]